| Literature DB >> 28357247 |
Matthias Wiemer1, Heinz D Osiewacz1.
Abstract
Aging of biological systems is influenced by various factors, conditions and processes. Among others, processes allowing organisms to deal with various types of stress are of key importance. In particular, oxidative stress as the result of the generation of reactive oxygen species (ROS) at the mitochondrial respiratory chain and the accumulation of ROS-induced molecular damage has been strongly linked to aging. Here we view the impact of ROS from a different angle: their role in the control of gene expression. We report a genome-wide transcriptome analysis of the fungal aging model Podospora anserina grown on medium containing paraquat (PQ). This treatment leads to an increased cellular generation and release of H2O2, a reduced growth rate, and a decrease in lifespan. The combined challenge by PQ and copper has a synergistic negative effect on growth and lifespan. The data from the transcriptome analysis of the wild type cultivated under PQ-stress and their comparison to those of a longitudinal aging study as well as of a copper-uptake longevity mutant of P. anserina revealed that PQ-stress leads to the up-regulation of transcripts coding for components involved in mitochondrial remodeling. PQ also affects the expression of copper-regulated genes suggesting an increase of cytoplasmic copper levels as it has been demonstrated earlier to occur during aging of P. anserina and during senescence of human fibroblasts. This effect may result from the induction of the mitochondrial permeability transition pore via PQ-induced ROS, leading to programmed cell death as part of an evolutionary conserved mechanism involved in biological aging and lifespan control.Entities:
Keywords: Aging; copper; mitochondria; oxidative stress; paraquat; programmed cell death; transcriptome
Year: 2014 PMID: 28357247 PMCID: PMC5349155 DOI: 10.15698/mic2014.07.155
Source DB: PubMed Journal: Microb Cell ISSN: 2311-2638
Global gene regulation in the P. anserina wild type stressed by PQ and during aging.
The table shows the number of differentially regulated genes (factor < 3; pV < 0.01) of all analyzed transcriptome data. In the individual columns two data sets are compared (i.e. aging and PQ stress in juvenile cultures), respectively. The lines show the number of differentially expressed genes at the specified treatment. The amount of differentially regulated transcripts in the specific direction in both treatments is depicted in the line ‘conjoint regulated’. The statistical expectation (‘stat. expectation’) provides the number of genes which is expected to be regulated if the two treatments initiate random gene regulation. The p-value was calculated by Fisher’s exact test. Since the calculation of p-values lower than 2.2e-16 are identical, we included the odds ratio to clarify the level of similarity in transcript generation. The odds ratio is a measure for statistical dependence. A high odds ratio indicates a high probability for a regulation of a gene in the same direction during both compared condition.
| Aging | 509 | 774 | ||||||||
| PQ juv | 683 | 1172 | 683 | 1172 | 683 | 1172 | 683 | 1172 | ||
| PQ ma | 933 | 1460 | 933 | 1460 | ||||||
| PQ sen | 1270 | 1854 | 1270 | 1854 | ||||||
| Grisea | 608 | 556 | ||||||||
| Conjoint regulated | 89 | 210 | 305 | 746 | 387 | 746 | 405 | 793 | 167 | 267 |
| Stat. expectation | 35 | 90 | 64 | 172 | 87 | 217 | 119 | 273 | 43 | 67 |
| p-value | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 | 2.2e-16 |
| Odds ratio | 3.19 | 3.21 | 11.06 | 19.71 | 12.51 | 12.23 | 7.20 | 8.30 | 6.29 | 8.41 |
GO enrichment analysis of transcriptome data of juvenile PQ-stressed P. anserina showing differential expression.
All differentially expressed genes (Factor < 3; pV < 0.01) were analyzed. GO terms with pV < 1E-5 are shown. The GO terms referred to in the text are highlighted in bold. CC: Cellular Component; BP: Biological Process; C: Count (number of genes of respective GO Term in the group (up- or down-regulated)); S: Size (total number of P. anserina genes with the respective GO term).
| CC | GO:0044429 | 4.08E-22 | 101 | 581 | mitochondrial part |
| GO:0005739 | 8.68E-19 | 144 | 1121 | mitochondrion | |
| GO:0005743 | 5.39E-17 | 57 | 261 | ||
| GO:0019866 | 2.34E-16 | 57 | 269 | organelle inner membrane | |
| GO:0005740 | 2.15E-15 | 71 | 408 | mitochondrial envelope | |
| GO:0031966 | 2.06E-13 | 65 | 386 | mitochondrial membrane | |
| GO:0044455 | 6.74E-13 | 38 | 159 | mitochondrial membrane part | |
| GO:0005759 | 7.56E-12 | 43 | 212 | ||
| GO:0031967 | 2.26E-09 | 75 | 584 | organelle envelope | |
| GO:0031975 | 4.99E-09 | 77 | 617 | envelope | |
| GO:0005744 | 2.86E-07 | 8 | 13 | mitochondrial inner membrane presequence translocase complex | |
| GO:0005758 | 5.06E-06 | 12 | 40 | ||
| GO:0031305 | 4.79E-05 | 6 | 12 | integral to mitochondrial inner membrane | |
| BP | GO:0006839 | 1.97E-14 | 34 | 113 | mitochondrial transport |
| GO:0007005 | 2.31E-13 | 50 | 243 | mitochondrion organization | |
| GO:0006626 | 1.94E-09 | 19 | 57 | protein targeting to mitochondrion | |
| GO:0070585 | 3.75E-09 | 19 | 59 | protein localization to mitochondrion | |
| GO:0009060 | 1.40E-07 | 25 | 117 | aerobic respiration | |
| GO:0030150 | 7.04E-07 | 9 | 18 | protein import into mitochondrial matrix | |
| GO:0006744 | 1.61E-06 | 8 | 15 | ubiquinone biosynthetic process | |
| GO:0045333 | 4.81E-06 | 33 | 215 | cellular respiration | |
| GO:0065002 | 5.37E-06 | 11 | 33 | intracellular protein transmembrane transport | |
| GO:0055114 | 8.04E-06 | 49 | 388 | oxidation-reduction process | |
| GO:0032543 | 9.53E-06 | 15 | 62 | mitochondrial translation | |
| GO:0017038 | 1.16E-05 | 22 | 120 | protein import | |
| GO:0015980 | 2.10E-05 | 36 | 261 | energy derivation by oxidation of organic compounds | |
| GO:0042180 | 2.10E-05 | 81 | 781 | cellular ketone metabolic process | |
| GO:0007007 | 3.87E-05 | 7 | 16 | inner mitochondrial membrane organization | |
| GO:0006091 | 3.89E-05 | 43 | 344 | generation of precursor metabolites and energy | |
| GO:0044281 | 4.66E-05 | 130 | 1438 | small molecule metabolic process | |
| GO:0006520 | 8.47E-05 | 59 | 541 | cellular amino acid metabolic process | |
| GO:0000002 | 8.66E-05 | 11 | 43 | mitochondrial genome maintenance | |
| GO:0006627 | 9.41E-05 | 4 | 5 | protein processing involved in protein targeting to mitochondrion | |
| MF | GO:0008320 | 7.45E-08 | 11 | 23 | protein transmembrane transporter activity |
| GO:0015450 | 3.15E-07 | 10 | 21 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity | |
| GO:0016491 | 8.58E-05 | 166 | 1920 | oxidoreductase activity | |
| BP | GO:0042438 | 4.97E-07 | 9 | 21 | |
| GO:0032787 | 6.47E-07 | 32 | 236 | monocarboxylic acid metabolic process | |
| GO:0006725 | 4.29E-06 | 28 | 209 | cellular aromatic compound metabolic process | |
| GO:0006582 | 5.96E-06 | 9 | 27 | melanin metabolic process | |
| GO:0044550 | 8.58E-06 | 10 | 35 | secondary metabolite biosynthetic process | |
| GO:0019748 | 1.57E-05 | 11 | 45 | secondary metabolic process | |
| GO:0006083 | 7.08E-05 | 6 | 15 | acetate metabolic process | |
| MF | GO:0016491 | 8.73E-17 | 193 | 1920 |
|
| GO:0004497 | 5.16E-11 | 49 | 298 | ||
| GO:0004312 | 2.80E-07 | 16 | 60 |
| |
| GO:0016705 | 2.82E-07 | 54 | 442 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of … | |
| GO:0005506 | 3.36E-07 | 58 | 492 | iron ion binding | |
| GO:0016701 | 1.99E-06 | 23 | 129 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | |
| GO:0020037 | 2.54E-06 | 45 | 366 | heme binding | |
| GO:0046906 | 2.95E-06 | 45 | 368 | tetrapyrrole binding | |
| GO:0046872 | 7.29E-06 | 201 | 2627 | metal ion binding | |
| GO:0004316 | 7.77E-06 | 10 | 31 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | |
| GO:0046914 | 8.28E-06 | 162 | 2022 | transition metal ion binding | |
| GO:0009055 | 2.14E-05 | 46 | 409 | electron carrier activity | |
| GO:0043169 | 2.32E-05 | 208 | 2781 | cation binding | |
| GO:0016614 | 3.58E-05 | 51 | 480 | oxidoreductase activity, acting on CH-OH group of donors | |
| GO:0070330 | 4.41E-05 | 10 | 37 | aromatase activity | |
| GO:0016616 | 5.28E-05 | 44 | 399 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | |
| GO:0016702 | 6.01E-05 | 19 | 117 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen… | |
| GO:0008709 | 7.86E-05 | 5 | 9 | cholate 7-alpha-dehydrogenase activity | |
Comparison of enriched GO terms in the data set of PQ-stressed P. anserina cultures with those from an earlier longitudinal aging study 19.
Terms that are enriched in the same group (up- or down-regulated) during aging and PQ-stress are highlighted in bold. Similar GO terms are grouped. CC: Cellular Component; BP: Biological Process; C: Count (number of genes of respective GO Term in the group (up- or down-regulated)); S: Size (total number of P. anserina genes with the respective GO term).
| 44429 | 7.5E-03 | 152 | 581 | up | 1.03E-63 | 318 | |||
| 44429 | 9.3E-06 | 171 | 581 | mitochondrial part | down | ||||
| 5746 | 5.2E-03 | 23 | 62 | mitochondrial respiratory chain | down | ||||
| 5746 | 2.1E-03 | 24 | 62 | up | 9.08E-18 | 47 | |||
| 70469 | 3.9E-03 | 27 | 75 | up | 7.27E-16 | 51 | |||
| 45333 | 2.4E-03 | 65 | 215 | up | 1.09E-22 | 117 | |||
| 45333 | 4.1E-04 | 68 | 215 | cellular respiration | down | ||||
| 502 | 1.7E-04 | 35 | 89 | down | 5.75E-03 | 28 | |||
| 31597 | 1.6E-03 | 13 | 26 | down | 2.08E-03 | 12 | |||
| 34515 | 1.6E-03 | 13 | 26 | down | 2.08E-03 | 12 | |||
| 43248 | 1.3E-03 | 12 | 23 | down | 7.83E-03 | 10 | |||
| 22626 | 3.5E-11 | 50 | 94 | down | 3.75E-11 | 47 | |||
| 5840 | 2.2E-08 | 126 | 367 | down | 8.66E-04 | 97 | |||
| 22627 | 6.7E-07 | 23 | 39 | down | 2.25E-06 | 21 | |||
| 15935 | 6.9E-07 | 30 | 58 | down | 1.00E-03 | 22 | |||
| 22625 | 2.9E-05 | 23 | 46 | down | 9.10E-07 | 24 | |||
| 15934 | 4.2E-05 | 35 | 84 | down | 4.44E-04 | 30 | |||
| 44391 | 3.1E-09 | 61 | 137 | ribosomal subunit | down | 1.47E-09 | 65 | ||
| 6090 | 2.2E-05 | 18 | 32 | pyruvate metabolic process | down | ||||